Keywords: Aβ1-42; AOF; Alpinae Oxyphyllae Fructus; AD; Alzheimer's disease; LPS; lipopolysaccharide; CT; control; MD; model; DPZ; donepezil; TT; total; PE; petroleum ether; CF; chloroform; EA; ethyl acetate; NB; n-butanol; WT; water; MWM; Morris water maze; HE; Hematoxylin
مقالات ISI Aβ1-42 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Aβ1-42; Alzheimer's disease; Amyloid-β; β-secretases; γ-secretases; Computer-Aided Drug Design; AD; Alzheimer's disease; Aβ1-40; beta-Amyloid isoform 40 amino acids in length; Aβ1-42; beta-Amyloid isoform 42 amino acids in length; NMDA; N-Methyl-d-aspart
Keywords: Aβ1-42; Preclinical AD; Neural exosomes; P-Tau; Aβ1-42; Biomarkers;
Keywords: Aβ1-42; Alzheimer's disease; Mild cognitive impairment; Cerebrospinal fluid; Plasma; Biomarkers; Immunoassay; ADNI; Disease-modifying therapy; Aβ1-42; Tau;
Keywords: Aβ1-42; α2M; α2-macroglobulin; LRP; lipoprotein receptor-related protein; trypsin-α2M; trypsin-activated α2M; (i)trypsin-α2M; trypsin-activated α2M treated with small molecule protease inhibitors; ThT; thioflavin T; α2-Macroglobulin; Extracellular chaperon
Keywords: Aβ1-42; Alzheimer's disease; Mild cognitive impairment; Dementia; Magnetic resonance imaging; Medial temporal lobe atrophy; Cerebrospinal fluid (CSF); Aβ1-42; Tau;
Lycopene mitigates β-amyloid induced inflammatory response and inhibits NF-κB signaling at the choroid plexus in early stages of Alzheimer's disease rats
Keywords: Aβ1-42; Choroid plexus; Lycopene; NF-κB; Inflammation; Aβ1-42; Neuroprotection;
Hydrogen sulfide inhibits ATP-induced neuroinflammation and Aβ1-42 synthesis by suppressing the activation of STAT3 and cathepsin S
Keywords: Aβ1-42; Hydrogen sulfide; Neuroinflammation; Aβ1-42; STAT3; Cathepsin S; Persulfidation; Microglia;
Quantum dots-based sandwich immunoassay for sensitive detection of Alzheimer's disease-related Aβ1-42
Keywords: Aβ1-42; Quantum dots; Sandwich immunoassay; Alzheimer's disease; Aβ1-42;
Plasma β-amyloid1-42 reference values in cognitively normal subjects
Keywords: Aβ1-42; Aβ; Amyloid β; AD; Alzheimer's disease; Aβ1-42; β-Amyloid1-42; Aβ1-40; β-Amyloid1-40; ELISA; Enzyme-linked Immunosorbent Assay; SPs; senile plaques; APP; Amyloid Protein Precursor; PET; Positron Emission Tomography; CSF; cerebrospinal fluid;
Neuroprotective effects of INT-777 against Aβ1-42-induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
Keywords: Aβ1-42; Alzheimer's disease; INT-777; TGR5; Aβ1-42; Neurotoxicity; Cognitive; Neuroinflammation; Apoptosis; Synaptic dysfunction; Memory;
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation
Keywords: Aβ1-42; Alzheimer's disease; Aβ1-42; Cerebrospinal fluid; Reference measurement procedure; Certified reference material;
Synthetic toxic Aβ1-42 oligomers can assemble in different morphologies
Keywords: Aβ1-42; Amyloid; Aβ1-42; Membrane; Oligomers;
Comparative effects of EtOH consumption and thiamine deficiency on cognitive impairment, oxidative damage, and β-amyloid peptide overproduction in the brain
Keywords: Aβ1-42; TD; thiamine deficiency; MDA; malondialdehyde; NO; nitric oxide; Aβ1-42; β-amyloid peptide 1-42; Aβ1-40; β-amyloid peptide 1-40; Glu; glutamic acid; ACh; acetylcholine; AChE; acetylcholinesterase; ChAT; choline acetyltransferase; MAO-B; monoam
Schisantherin B ameliorates Aβ1-42-induced cognitive decline via restoration of GLT-1 in a mouse model of Alzheimer's disease
Keywords: Aβ1-42; Schisantherin B; Alzheimer's disease; Aβ1-42; tau; GLT-1; GSK3β;
Leptin attenuates the detrimental effects of β-amyloid on spatial memory and hippocampal later-phase long term potentiation in rats
Keywords: Aβ1-42; Leptin; Aβ1-42; Spatial learning and memory; Later-phase long term potentiation; Synaptic plasticity;
Protective effect of n-butanol extract from Alpinia oxyphylla on learning and memory impairments
Keywords: Aβ1-42; Alpinia oxyphylla Miq.; Alzheimer's disease; Blood-brain barrier; Aβ1-42;
Lycopene abrogates Aβ(1-42)-mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease
Keywords: Aβ1-42; Lycopene; Aβ1-42; Cognitive impairment; Neuroinflammation; Oxidative stress;
Correlation between decreased CSF α-synuclein and Aβ1-42 in Parkinson disease
Keywords: Aβ1-42; Parkinson's disease; Cerebrospinal fluid; α-Synuclein; Aβ1-42; Tau; Nondemented; PiB; Imaging;
Accumulation and age-related elevation of amyloid-β within basal forebrain cholinergic neurons in the rhesus monkey
Keywords: Aβ1-42; Aβ; amyloid-β; Aβ1-40; 1-40 amino acid isoform of Aβ; Aβ1-42; 1-42 amino acid isoform of Aβ; AD; Alzheimer's disease; APP; amyloid precursor protein; BFCN; basal forebrain cholinergic neurons; Ca2 +; calcium; Ch4; cholinergic cell group 4;
The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function
Keywords: Aβ1-42; AD; Alzheimer's disease; ADAS-Cog; Alzheimer Disease's Assessment Scale-cognitive subscale; ADNI; Alzheimer's Disease Neuroimaging; ApoE; Apolipoprotein E; Aβ; β-amyloid; Aβ1-42; β-amyloid peptides 1 to 42; Bc; Bias-corrected; CFI; Comparative f
Simultaneous measurement of a range of particle sizes during Aβ1-42 fibrillogenesis quantified using fluorescence correlation spectroscopy
Keywords: Aβ1-42; Aβ; amyloid β-protein; Aβ1-42; Aβ spanning residues from Asp1 to Ala42; AD; Alzheimer's disease; CSF; cerebrospinal fluid; 5GDM; five Gaussian distribution model; FCS; fluorescence correlation spectroscopy; MEMFCS; maximum entropy method for FCS d
New insights concerning insulin synthesis and its secretion in rat hippocampus and cerebral cortex: Amyloid-β1-42-induced reduction of proinsulin level via glycogen synthase kinase-3β
Keywords: Aβ1-42; Aβ1-42; amyloid-β1-42; CAPS2; Ca2 +-dependent activator protein for secretion 2; CSF; cerebrospinal fluid; DMSO; dimethyl sulfoxide; GSK-3α; glycogen synthase kinase-3α; GSK-3β; glycogen synthase kinase-3β; pHluorin; pH-sensitive green fluoresc
Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation
Keywords: Aβ1-42; Retinoic acid; Aβ1-42; RAGE; AMIGO-1; Aβ peptide molecular assembly;
Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ1-42
Keywords: Aβ1-42; Alzheimer׳s disease; Jujuboside A; Aβ1-42; Antioxidant; Anti-inflammation;
Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo
Keywords: Aβ1-42; Cysteinyl leukotriene receptor 1; Aβ1-42; Neurotoxicity; NF-κB; Caspase-3; Bcl-2; Memory;
Pharmaceutical nanotechnologyCardiolipin-incorporated liposomes with surface CRM197 for enhancing neuronal survival against neurotoxicity
Keywords: Aβ1-42; AD; Alzheimer's disease; Aβ1-42; β-amyloid peptide (1-42); BBB; blood-brain barrier; CL; cardiolipin, diphosphatidylglycerol; CL-liposome; cardiolipin-incorporated liposome (without surface CRM197); CNS; central nervous system; CRM197; cross-rea
Norepinephrine provides short-term neuroprotection against Aβ1-42 by reducing oxidative stress independent of Nrf2 activation
Keywords: Aβ1-42; Alzheimer's disease; Aβ1-42; Norepinephrine; Oxidative stress; Redox cycling; Nrf2 pathway;
Modeling the binding mechanism of Alzheimer's Aβ1-42 to nicotinic acetylcholine receptors based on similarity with snake α-neurotoxins
Keywords: Aβ1-42; AChR; acetylcholine receptor; αAChR; acetylcholine receptor α-subunit; AD; Alzheimer's disease; Aβ; amyloid β; Aβ1-42; 42 amino acid amyloid β peptide, DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA; Aβ1-40; same as Aβ1-42 without two last resid
Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease
Keywords: Aβ1-42; Pseudoginsenoside-F11; Aβ1-42; APP/PS1 mice; APP; Oxidative stress; Apoptosis;
Blockage of CR1 prevents activation of rodent microglia
Keywords: Aβ1-42; Aβ; amyloid beta; AD; Alzheimer's disease; Apo; apocynin; APP; amyloid precursor protein; CGC; cerebellar granule cells; CR1; complement receptor 1; DIV; days in vitro; DHE; dihydroethidium; D-MEM; Dulbecco's modified eagle medium; EA; ethacrynic acid; E
Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-β induced experimental model of Alzheimer's disease
Keywords: Aβ1-42; GCSF; granulocyte colony-stimulating factor; ICV; intracerebroventricular; AD; Alzheimer's disease; Aβ1-42; amyloid-beta (1-42); DG; dentate gyrus; NMDA; N-methyl-d-aspartate; EPO; erythropoietin; BDNF; brain-derived neurotrophic factors; NBT; nitro
The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia
Keywords: Aβ1-42; LPS; lipopolysaccharide; MLA; methyllycaconitine; MAPK; mitogenâactivated protein kinase; nAChR; nicotinic acetylcholine receptor; PAM; positive allosteric modulator; HFIP; 1,1,1,3,3,3âhexafluoroâ2âpropanol; Nicotinic acetylcholine receptor; Infla
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease
Keywords: Aβ1-42; Alzheimer's disease; Body mass index; Cerebrospinal fluid; Tau protein; Aβ1-42;
Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI
Keywords: Aβ1-42; Alzheimer's disease (AD); Dementia; Mild cognitive impairment (MCI); cerebrospinal fluid (CSF); Aβ1-42; Tau; Magnetic resonance imaging (MRI); Volumetry; Hippocampus; Diagnostic test sequence;
Intranasal administration of TAT-haFGF14-154 attenuates disease progression in a mouse model of Alzheimer's disease
Keywords: Aβ1-42; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; Aβ1-42; β-amyloid protein1-42; BBB; blood-brain barrier; BCA; bicinchoninic acid; ChAT; choline acetyltransferase; ELISA; enzyme-linked immunosorbent assay; GSH-Px; glutath
PerspectiveAlzheimer's disease, a multifactorial disorder seeking multitherapies
Keywords: Aβ1-42; Alzheimer disease subgroups; Cerebrospinal fluid; CSF biomarkers; Aβ1-42; Tau; Ubiquitin; Alzheimer disease therapeutics; Neurofibrillary degeneration; β-amyloid;
Cerebrospinal fluid tau, Aβ1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia
Keywords: Aβ1-42; Alzheimer's disease; Vascular dementia; Total tau; Phospho-tau; Aβ1-42; Cytokines;
Chronic treatment with amyloid β1-42 inhibits non-cholinergic high-affinity choline transport in NG108-15 cells through protein kinase C signaling
Keywords: Aβ1-42; Disorders of the nervous system; Degenerative disease: Alzheimer's beta amyloid; Amyloid β-peptide1-42; Aβ1-42; Amyloid Precursor Protein; APP; Hemicholinum-3; HC-3; Choline Transporter-like Protein 1; CTL1; High-affinity choline transporter 1; ChT1